Cochlear Limited CHEOY
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 406.58M | 405.00M | 383.04M | 381.83M | 375.17M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 406.58M | 405.00M | 383.04M | 381.83M | 375.17M |
| Cost of Revenue | 127.03M | 126.54M | 104.75M | 104.42M | 101.76M |
| Gross Profit | 279.55M | 278.47M | 278.29M | 277.41M | 273.41M |
| SG&A Expenses | 164.92M | 164.28M | 147.48M | 147.01M | 150.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -2.34M | -2.33M | -2.13M | -2.13M | -2.66M |
| Total Operating Expenses | 348.30M | 346.95M | 300.24M | 299.29M | 294.74M |
| Operating Income | 58.28M | 58.05M | 82.80M | 82.53M | 80.43M |
| Income Before Tax | 275.60K | 274.50K | 69.93M | 69.71M | 77.58M |
| Income Tax Expenses | 5.17M | 5.15M | 16.93M | 16.88M | 18.71M |
| Earnings from Continuing Operations | -4.89M | -4.87M | 53.00M | 52.83M | 58.87M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.89M | -4.87M | 53.00M | 52.83M | 58.87M |
| EBIT | 58.28M | 58.05M | 82.80M | 82.53M | 80.43M |
| EBITDA | 60.62M | 60.39M | 99.73M | 99.41M | 82.67M |
| EPS Basic | -0.07 | -0.07 | 0.81 | 0.81 | 0.90 |
| Normalized Basic EPS | 0.57 | 0.57 | 0.80 | 0.80 | 0.75 |
| EPS Diluted | -0.07 | -0.07 | 0.81 | 0.81 | 0.90 |
| Normalized Diluted EPS | 0.57 | 0.57 | 0.80 | 0.80 | 0.75 |
| Average Basic Shares Outstanding | 65.42M | 65.42M | 65.42M | 65.42M | 65.41M |
| Average Diluted Shares Outstanding | 65.42M | 65.42M | 65.54M | 65.54M | 65.59M |
| Dividend Per Share | 0.45 | 0.45 | 0.71 | 0.70 | 0.69 |
| Payout Ratio | -990.14% | -990.14% | 87.06% | 87.06% | 76.55% |